GE Healthcare will acquire PAA Laboratories, a developer and supplier of cell culture media for biopharmaceutical research and vaccine manufacturing. The acquisition expands GE Healthcare’s offering of products and services for cell biology research and the discovery and manufacture of biopharmaceuticals including recombinant proteins, antibodies and vaccines. Financial terms were not disclosed. PAA Laboratories develops and manufactures specialized cell culture products such as media, sera, gr...